Profiles

Keywords
Last Name
Institution

Shahram Oveisgharan

TitleInstructor
InstitutionRush University, Rush Medical College
DepartmentBehavioral Sciences
Address
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    My ORCID is 0000-0001-6841-4830.
    My Scopus ID is 15052253000.


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Nazari F, Sinaei F, Nilipour Y, Petit F, Oveisgharan S, Nassiri-Toosi M, Razzaghy-Azar M, Mahmoudi M, Nafissi S. Distinct Clinical and Genetic Findings in Iranian Patients With Glycogen Storage Disease Type 3. J Clin Neuromuscul Dis. 2018 Jun; 19(4):203-210. PMID: 29794575.
      View in: PubMed
    2. Langhorne P, O'Donnell MJ, Chin SL, Zhang H, Xavier D, Avezum A, Mathur N, Turner M, MacLeod MJ, Lopez-Jaramillo P, Damasceno A, Hankey GJ, Dans AL, Elsayed A, Mondo C, Wasay M, Czlonkowska A, Weimar C, Yusufali AH, Hussain FA, Lisheng L, Diener HC, Ryglewicz D, Pogosova N, Iqbal R, Diaz R, Yusoff K, Oguz A, Wang X, Penaherrera E, Lanas F, Ogah OS, Ogunniyi A, Iversen HK, Malaga G, Rumboldt Z, Magazi D, Nilanont Y, Rosengren A, Oveisgharan S, Yusuf S. Practice patterns and outcomes after stroke across countries at different economic levels (INTERSTROKE): an international observational study. Lancet. 2018 May 19; 391(10134):2019-2027. PMID: 29864018.
      View in: PubMed
    3. Oveisgharan S, Buchman AS, Yu L, Farfel J, Hachinski V, Gaiteri C, De Jager PL, Schneider JA, Bennett DA. APOE e2e4 genotype, incident AD and MCI, cognitive decline, and AD pathology in older adults. Neurology. 2018 Jun 12; 90(24):e2127-e2134. PMID: 29752306.
      View in: PubMed
    4. Soleimani A, Pourmoghaddas A, Sadeghi M, Roohafza H, Talaei M, Dianatkhah M, Oveisgharan S, Soleimani M, Sarrafzadegan N. Risk and Age of Cardiovascular Event in Women with Metabolic Syndrome: Menopause Age in Focus. Metab Syndr Relat Disord. 2018 Apr; 16(3):127-134. PMID: 29437523.
      View in: PubMed
    5. Sarrafzadegan N, Hassannejad R, Marateb HR, Talaei M, Sadeghi M, Roohafza HR, Masoudkabir F, Oveisgharan S, Mansourian M, Mohebian MR, Mañanas MA. Correction: PARS risk charts: A 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region. PLoS One. 2018; 13(1):e0191379. PMID: 29370204.
      View in: PubMed
    6. Sarrafzadegan N, Hassannejad R, Marateb HR, Talaei M, Sadeghi M, Roohafza HR, Masoudkabir F, Oveisgharan S, Mansourian M, Mohebian MR, Mañanas MA. PARS risk charts: A 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region. PLoS One. 2017; 12(12):e0189389. PMID: 29261727.
      View in: PubMed
    7. Talaei M, Hosseini N, van Dam RM, Sadeghi M, Oveisgharan S, Dianatkhah M, Sarrafzadegan N. Whole milk consumption and risk of cardiovascular disease and mortality: Isfahan Cohort Study. Eur J Nutr. 2017 Nov 18. PMID: 29151136.
      View in: PubMed
    8. Bahonar A, Khosravi A, Khorvash F, Maracy M, Oveisgharan S, Mohammadifard N, Saadatnia M, Nouri F, Sarrafzadegan N. Ten-year trend in stroke incidence and its subtypes in Isfahan, Iran during 2003-2013. Iran J Neurol. 2017 Oct 07; 16(4):201-209. PMID: 29736226.
      View in: PubMed
    9. Oveisgharan S, Organji H, Ghorbani A. Enhancement of Motor Recovery through Left Dorsolateral Prefrontal Cortex Stimulation after Acute Ischemic Stroke. J Stroke Cerebrovasc Dis. 2018 Jan; 27(1):185-191. PMID: 28893574.
      View in: PubMed
    10. Sadeghi M, Soleimani A, Roohafza H, Yazdekhasti S, Oveisgharan S, Talaei M, Sarrafzadegan N. Cardiovascular disease events and its predictors in women: Isfahan Cohort Study (ICS). J Cardiovasc Thorac Res. 2017; 9(3):158-163. PMID: 29118949.
      View in: PubMed
    11. Hosseini N, Talaei M, Dianatkhah M, Sadeghi M, Oveisgharan S, Sarrafzadegan N. Determinants of Incident Metabolic Syndrome in a Middle Eastern Population: Isfahan Cohort Study. Metab Syndr Relat Disord. 2017 09; 15(7):354-362. PMID: 28677982.
      View in: PubMed
    12. Chong M, O'Donnell M, Thijs V, Dans A, López-Jaramillo P, Gómez-Arbeláez D, Mondo C, Czlonkowska A, Skowronska M, Oveisgharan S, Yusuf S, Paré G. Mendelian Genes and Risk of Intracerebral Hemorrhage and Small-Vessel Ischemic Stroke in Sporadic Cases. Stroke. 2017 08; 48(8):2263-2265. PMID: 28679849.
      View in: PubMed
    13. Oveisgharan S, Hachinski V. Atherosclerosis and vascular cognitive impairment neuropathological guideline. Brain. 2017 02; 140(2):e12. PMID: 28007992.
      View in: PubMed
    14. Sarrafzadegan N, Gharipour M, Sadeghi M, Nezafati P, Talaie M, Oveisgharan S, Nouri F, Khosravi A. Metabolic Syndrome and the Risk of Ischemic Stroke. J Stroke Cerebrovasc Dis. 2017 Feb; 26(2):286-294. PMID: 27769610.
      View in: PubMed
    15. Nabaei G, Oveisgharan S, Ghorbani A, Fatehi F. Impaired arterial smooth muscle cell vasodilatory function in methamphetamine users. J Neurol Sci. 2016 Nov 15; 370:107-111. PMID: 27772737.
      View in: PubMed
    16. O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, Rao-Melacini P, Zhang X, Pais P, Agapay S, Lopez-Jaramillo P, Damasceno A, Langhorne P, McQueen MJ, Rosengren A, Dehghan M, Hankey GJ, Dans AL, Elsayed A, Avezum A, Mondo C, Diener HC, Ryglewicz D, Czlonkowska A, Pogosova N, Weimar C, Iqbal R, Diaz R, Yusoff K, Yusufali A, Oguz A, Wang X, Penaherrera E, Lanas F, Ogah OS, Ogunniyi A, Iversen HK, Malaga G, Rumboldt Z, Oveisgharan S, Al Hussain F, Magazi D, Nilanont Y, Ferguson J, Pare G, Yusuf S. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016 Aug 20; 388(10046):761-75. PMID: 27431356.
      View in: PubMed
    17. Dadjou Y, Kermani-Alghoraishi M, Sadeghi M, Talaei M, Yousefy A, Oveisgharan S, Roohafza H, Rabiei K, Sarrafzadegan N. The impact of health-related quality of life on the incidence of ischaemic heart disease and stroke; a cohort study in an Iranian population. Acta Cardiol. 2016 Apr; 71(2):221-6. PMID: 27090045.
      View in: PubMed
    18. Aalami Harandi S, Sarrafzadegan N, Sadeghi M, Talaei M, Dianatkhah M, Oveisgharan S, Pourmoghaddas A, Salehi A, Sedighifard Z. Do Cardiometabolic Risk Factors Relative Risks Differ for the Occurrence of Ischemic Heart Disease and Stroke? Res Cardiovasc Med. 2016 Feb; 5(1):e30619. PMID: 26889461; PMCID: PMC4752672.
    19. Oveisgharan S, Ghaemmaghami AB, Bahonar A, Sarrafzadegan N. Case fatality rate ?and disability of stroke in Isfahan, Iran: Isfahan stroke registry. Iran J Neurol. 2016 Jan 05; 15(1):9-15. PMID: 27141271; PMCID: PMC4852074.
    20. Oveisgharan S, Hachinski V. Simple Neuropsychological Tests May Identify Participants in Whom Aspirin Use Is Associated With Lower Dementia Incidence: The Canadian Study of Health and Aging. Am J Alzheimers Dis Other Demen. 2016 11; 31(7):545-550. PMID: 26705378.
      View in: PubMed
    21. Fallahi B, Esmaeili A, Beiki D, Oveisgharan S, Noorollahi-Moghaddam H, Erfani M, Tafakhori A, Rohani M, Fard-Esfahani A, Emami-Ardekani A, Geramifar P, Eftekhari M. Evaluation of (99m)Tc-TRODAT-1 SPECT in the diagnosis of Parkinson's disease versus other progressive movement disorders. Ann Nucl Med. 2016 Feb; 30(2):153-62. PMID: 26612262.
      View in: PubMed
    22. Gharipour M, Sadeghi M, Dianatkhah M, Nezafati P, Talaie M, Oveisgharan S, Golshahi J. Comparison between European and Iranian cutoff points of triglyceride/high-density lipoprotein cholesterol concentrations in predicting cardiovascular disease outcomes. J Clin Lipidol. 2016 Jan-Feb; 10(1):143-9. PMID: 26892131.
      View in: PubMed
    23. Oveisgharan S, Hachinski V. Executive dysfunction is a strong stroke predictor. J Neurol Sci. 2015 Feb 15; 349(1-2):161-7. PMID: 25614441.
      View in: PubMed
    24. Sadeghi M, Talaei M, Parvaresh Rizi E, Dianatkhah M, Oveisgharan S, Sarrafzadegan N. Determinants of incident prediabetes and type 2 diabetes in a 7-year cohort in a developing country: The Isfahan Cohort Study. J Diabetes. 2015 Sep; 7(5):633-41. PMID: 25350916.
      View in: PubMed
    25. Sadeghi M, Talaei M, Oveisgharan S, Rabiei K, Dianatkhah M, Bahonar A, Sarrafzadegan N. The cumulative incidence of conventional risk factors of cardiovascular disease and their population attributable risk in an Iranian population: The Isfahan Cohort Study. Adv Biomed Res. 2014; 3:242. PMID: 25538928; PMCID: PMC4260292.
    26. Sadeghi M, Talaei M, Zand I, Oveisgharan S, Iranipour R, Esteki Ghashghaei F, Sarrafzadegan N. Heart rate and cardiovascular events: a nested case-control in Isfahan Cohort Study. Arch Iran Med. 2014 Sep; 17(9):633-7. PMID: 25204481.
      View in: PubMed
    27. Rezazadeh A, Oveisgharan S, Shahidi G, Naghdi R. A Case Report of Homocystinuria With Dystonia and Stroke. Child Neurol Open. 2014 Jul-Sep; 1(1):2329048X14545870. PMID: 28503581.
      View in: PubMed
    28. Dianatkhah M, Rahgozar M, Talaei M, Karimloua M, Sadeghi M, Oveisgharan S, Sarrafzadegan N. Comparison of competing risks models based on cumulative incidence function in analyzing time to cardiovascular diseases. ARYA Atheroscler. 2014 Jan; 10(1):6-12. PMID: 24963307; PMCID: PMC4063516.
    29. Talaei M, Sadeghi M, Mohammadifard N, Shokouh P, Oveisgharan S, Sarrafzadegan N. Incident hypertension and its predictors: the Isfahan Cohort Study. J Hypertens. 2014 Jan; 32(1):30-8. PMID: 24048009.
      View in: PubMed
    30. Talaei M, Sarrafzadegan N, Sadeghi M, Oveisgharan S, Marshall T, Thomas GN, Iranipour R. Incidence of cardiovascular diseases in an Iranian population: the Isfahan Cohort Study. Arch Iran Med. 2013 Mar; 16(3):138-44. PMID: 23432164.
      View in: PubMed
    31. Hachinski V, Oveisgharan S, Shankle WR. Atrial fibrillation and the hachinski ischemic scale-reply. Arch Neurol. 2012 Aug 01; 69(8):1084-5. PMID: 23753774.
      View in: PubMed
    32. Sarrafzadegan N, Talaei M, Kelishadi R, Toghianifar N, Sadeghi M, Oveisgharan S, Kabiri P, Tavassoli A, Mohammadifard N, Thomas GN, Marshall T. The influence of gender and place of residence on cardiovascular diseases and their risk factors. The Isfahan cohort study. Saudi Med J. 2012 May; 33(5):533-40. PMID: 22588815.
      View in: PubMed
    33. Talaei M, Thomas GN, Marshall T, Sadeghi M, Iranipour R, Oveisgharan S, Sarrafzadegan N. Appropriate cut-off values of waist circumference to predict cardiovascular outcomes: 7-year follow-up in an Iranian population. Intern Med. 2012; 51(2):139-46. PMID: 22246480.
      View in: PubMed
    34. Hachinski V, Oveisgharan S, Romney AK, Shankle WR. Optimizing the Hachinski Ischemic Scale. Arch Neurol. 2012 Feb; 69(2):169-75. PMID: 21987392.
      View in: PubMed
    35. Oveisgharan S, Hachinski V. Hypertension, executive dysfunction, and progression to dementia: the canadian study of health and aging. Arch Neurol. 2010 Feb; 67(2):187-92. PMID: 20142526.
      View in: PubMed
    36. Hasanzadeh P, Oveisgharan S, Sedighi N, Nafissi S. Effect of skin thickness on sensory nerve action potential amplitude. Clin Neurophysiol. 2008 Aug; 119(8):1824-1828. PMID: 18487083.
      View in: PubMed
    37. Oveisgharan S, Sarrafzadegan N, Shirani S, Hosseini S, Hasanzadeh P, Khosravi A. Stroke in Isfahan, Iran: hospital admission and 28-day case fatality rate. Cerebrovasc Dis. 2007; 24(6):495-9. PMID: 17971627.
      View in: PubMed
    38. Oveisgharan S, Shirani S, Ghorbani A, Soltanzade A, Baghaei A, Hosseini S, Sarrafzadegan N. Barthel index in a Middle-East country: translation, validity and reliability. Cerebrovasc Dis. 2006; 22(5-6):350-4. PMID: 16888374.
      View in: PubMed
    Oveisgharan's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description